Newsfeeds - Spark Newswire

1 minute read

NuVasive Q4 EPS $0.43 Misses $0.51 Estimate, Sales $305.45M Miss $311.10M Estimate

Today, 8:31 PM

NuVasive (NASDAQ:NUVA) reported quarterly earnings of $0.43 per share which missed the analyst consensus estimate of $0.51 by 15.69 percent. This is a 7.5 percent increase over earnings of $0.40 per share from the same

NUVA

13 minute read

Earnings

Earnings Scheduled For February 22, 2023

By Benzinga Insights

Today, 8:31 PM

Companies Reporting Before The Bell • Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022.

ACVA

1 minute read

Wells Fargo Downgrades NuVasive to Equal-Weight, Raises Price Target to $57.72

By Benzinga Newsdesk

Today, 8:31 PM

Wells Fargo analyst Vik Chopra downgrades NuVasive (NASDAQ:NUVA) from Overweight to Equal-Weight and raises the price target from $47 to $57.72.

NUVA

1 minute read

Truist Securities Downgrades NuVasive to Hold, Announces $52.5 Price Target

By Benzinga Newsdesk

Today, 8:31 PM

Truist Securities analyst Richard Newitter downgrades NuVasive (NASDAQ:NUVA) from Buy to Hold and announces $52.5 price target.

NUVA

2 minute read

Analyst Ratings

Where NuVasive Stands With Analysts

By Benzinga Insights

Today, 8:31 PM

Analysts have provided the following ratings for NuVasive (NASDAQ:NUVA) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

NUVA

20 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For January 6, 2023

By Benzinga Insights

Today, 8:31 PM

Upgrades Piper Sandler upgraded the previous rating for Aligos Therapeutics Inc (NASDAQ:ALGS) from Neutral to Overweight. Aligos Therapeutics…

AGTI

8 minute read

Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 8:31 PM

OnThursday, 137 stocks made new 52-week lows.

AAP

2 minute read

Analyst Ratings

What 11 Analyst Ratings Have To Say About NuVasive

By Benzinga Insights

Today, 8:31 PM

Analysts have provided the following ratings for NuVasive (NASDAQ:NUVA) within the last quarter:

NUVA

7 minute read

Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 8:31 PM

During Thursday's session, 97 companies made new 52-week lows.

ACST

1 minute read

Barclays Initiates Coverage On NuVasive with Overweight Rating, Announces Price Target of $53

By Benzinga Newsdesk

Today, 8:31 PM

Barclays analyst Matt Miksic initiates coverage on NuVasive (NASDAQ:NUVA) with a Overweight rating and announces Price Target of $53.

NUVA